Therapeutic Potential of Targeting the Ghrelin Pathway

Ghrelin was discovered in 1999 as the endogenous ligand of the growth-hormone secretagogue receptor 1a (GHSR1a). Since then, ghrelin has been found to exert a plethora of physiological effects that go far beyond its initial characterization as a growth hormone (GH) secretagogue. Among the numerous w...

Descripción completa

Detalles Bibliográficos
Autores principales: Colldén, Gustav, Tschöp, Matthias H., Müller, Timo D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412382/
https://www.ncbi.nlm.nih.gov/pubmed/28398233
http://dx.doi.org/10.3390/ijms18040798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412382/
https://www.ncbi.nlm.nih.gov/pubmed/28398233
http://dx.doi.org/10.3390/ijms18040798

Ejemplares similares